Patents by Inventor Quinton Smith

Quinton Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250271419
    Abstract: Methods, systems, and kits for generating placenta-like organoids in suspension or placenta-on-a-chip systems are described herein, as well as methods of use thereof. A placental organoid composition has a plurality of trophoblast cells derived from naïve-like stem cells in suspension cultures. The placental organoid composition can be prepared by seeding a single-cell suspension onto a culture surface in a first medium, centrifuging and incubating the single-cell suspension to form aggregates. A portion of the first media is replaced with a differentiation media and the aggregates are incubated for a period of time during which the aggregates differentiate into placental organoids. The composition can be used to assess drug toxicity and drug screening.
    Type: Application
    Filed: February 28, 2025
    Publication date: August 28, 2025
    Inventors: Quinton Smith, Melisa J. Andrade, Eric Wang
  • Patent number: 11332717
    Abstract: Early vascular cells (EVCs), including endothelial cells and pericytes, are generated from hiPSCs. Unlike the isolated endothelial progenitor cells, the differentiated ECs mature and are functional. When encapsulated in synthetic hydrogel, EVCs respond to matrix cues and self-assembled to form three-dimensional EVCs. Moreover, these EVCs respond to hypoxic microenvironment and undergo vasculogenesis to form complex 3D networks.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: May 17, 2022
    Assignee: The Johns Hopkins University
    Inventors: Sharon Gerecht, Xin Yi Chan, Quinton Smith, Yu-I Shen
  • Publication number: 20180216063
    Abstract: Early vascular cells (EVCs), including endothelial cells and pericytes, are generated from hiPSCs. Unlike the isolated endothelial progenitor cells, the differentiated ECs mature and are functional. When encapsulated in synthetic hydrogel, EVCs respond to matrix cues and self-assembled to form three-dimensional EVCs. Moreover, these EVCs respond to hypoxic microenvironment and undergo vasculogenesis to form complex 3D networks.
    Type: Application
    Filed: July 21, 2016
    Publication date: August 2, 2018
    Inventors: Sharon Gerecht, Xin Yi Chan, Quinton Smith, Yu-I Shen